Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yield Go Holdings Ltd. ( (HK:1796) ) has shared an update.
Metaspacex Limited has entered into a strategic cooperation agreement with Xinhua Pharmaceutical Development to jointly explore opportunities in the TCM and big health industry in China. This collaboration aims to leverage complementary resources and synergistic development, focusing on AI-driven TCM standardization and modernization. The partnership is expected to enhance Metaspacex’s business operations and financial position, while Xinhua Pharmaceutical brings competitive advantages in the industry chain, technological innovation, and a clear strategic roadmap, making it an ideal partner for long-term growth and market recognition.
The most recent analyst rating on (HK:1796) stock is a Sell with a HK$2.50 price target. To see the full list of analyst forecasts on Yield Go Holdings Ltd. stock, see the HK:1796 Stock Forecast page.
More about Yield Go Holdings Ltd.
Metaspacex Limited, incorporated in the Cayman Islands, operates within the traditional Chinese medicine (TCM) and big health industry sectors in the People’s Republic of China. The company is focused on exploring cooperation opportunities in TCM resources development, production, supply chain, and market promotion of modern TCM products, integrating AI-driven standardization and modernization.
Average Trading Volume: 1,010,025
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.34B
Learn more about 1796 stock on TipRanks’ Stock Analysis page.